Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in federally qualified health centers

Preventive Medicine

Volumn 57, Issue 5, 2013, Pages 419-425

  Roland, K B ^a   Benard, V B ^a   Greek, A ^b   Hawkins, N A ^a   Manninen, D ^b   Saraiya, M ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

Cervical cancer screening; HPV testing; Screening guidelines

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CANCER PREVENTION; CANCER SCREENING; CROSS-SECTIONAL STUDY; FEMALE; HEALTH BELIEF; HEALTH CARE PERSONNEL; HEALTH CARE PRACTICE; HEALTH CARE SURVEY; HEALTH CENTER; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; LOWEST INCOME GROUP; MALE; MEDICAL LIABILITY; PAPANICOLAOU TEST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNITED STATES; UTERINE CERVIX CANCER; WOMEN'S HEALTH;

CERVICAL CANCER SCREENING; HPV TESTING; SCREENING GUIDELINES;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; CULTURE; EARLY DETECTION OF CANCER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES MISUSE; HEALTH SERVICES RESEARCH; HOSPITALS, FEDERAL; HUMANS; ILLINOIS; PAPILLOMAVIRUS INFECTIONS; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; UNITED STATES; UTERINE CERVICAL NEOPLASMS; UTILIZATION REVIEW; VAGINAL SMEARS;

EID: 84885868873     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2013.04.012     Document Type: Article

References (42)

1. ACOG Committee on Practice Bulletins-Gynecology ACOG practice bulletin no. 109: cervical cytology screening. Obstet. Gynecol. 2009, 114(6):1409-1420.
2. ACOG Committee on Practice Bulletins-Gynecology ACOG practice bulletin number 131: screening for cervical cancer. Obstet. Gynecol. 2012, 120(5):1222-1238.
3. Ahmad F., Stewart D.E., Cameron J.I., Hyman I. Rural physicians' perspectives on cervical and breast cancer screening: a gender-based analysis. J. Womens Health Gend. Based Med. 2001, 10(2):201-208.
4. Apgar B., Kittendorf A.L., Bettcher C.M., Wong J., Kaufman A.J. Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology. Am. Fam. Physician 2009, 80(2):147-155.
5. Benard V.B., Johnson C.J., Thompson T.D., et al. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer 2008, 113(10 Suppl.):2910-2918.
6. Benard V.B., Saraiya M., Soman A., Roland K.B., Yabroff K.R., Miller J. Cancer screening practices among physicians in the national breast and cervical cancer early detection program. J. Womens Health (Larchmt) 2011, 20(10):1479-1484.
7. Bentley T.G., Effros R.M., Palar K., Keeler E.B. Waste in the U.S. Health care system: a conceptual framework. Milbank Q. 2008, 86(4):629-659.
8. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 2002, 55(4):244-265.
9. Centers for Disease Control and Prevention Cancer screening - United States, 2010. MMWR Morb. Mortal. Wkly Rep. 2012, 61:41-45.
10. Centers for Disease Control and Prevention Human papillomavirus-associated cancers-United States, 2004-2008. MMWR Morb. Mortal. Wkly Rep. 2012, 61:258-261.
11. Clauser S.B., Taplin S.H., Foster M.K., Fagen P., Kaluzny A.D. Multilevel intervention research: lessons learned and pathways forward. J. Natl. Cancer Inst. Monogr. 2012, 2012(44):127-133.
12. Cuzick J., Arbyn M., Sankaranarayanan R., et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008, 26(Suppl. 10):K29-K41.
13. Davis D.A., Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 1997, 157(4):408-416.
14. Fedewa S.A., Cokkinides V., Virgo K.S., Bandi P., Saslow D., Ward E.M. Association of insurance status and age with cervical cancer stage at diagnosis: national cancer database, 2000-2007. Am. J. Public Health 2012, 102(9):1782-1790.
15. Good Stewardship Working Group The "top 5" lists in primary care: meeting the responsibility of professionalism. Arch. Intern. Med. 2011, 171(15):1385-1390.
16. Gorin S.S., Ashford A.R., Lantigua R., et al. Effectiveness of academic detailing on breast cancer screening among primary care physicians in an underserved community. J. Am. Board Fam. Med. 2006, 19(2):110-121.
17. Habbema D., De Kok I.M., Brown M.L. Cervical cancer screening in the United States and the Netherlands: a tale of two countries. Milbank Q. 2012, 90(1):5-37.
18. Holland-Barkis P., Forjuoh S.N., Couchman G.R., Capen C., Rascoe T.G., Reis M.D. Primary care physicians' awareness and adherence to cervical cancer screening guidelines in Texas. Prev. Med. 2006, 42(2):140-145.
19. Idestrom M., Milsom I., Andersson-Ellstrom A. Women's experience of coping with a positive Pap smear: a register-based study of women with two consecutive Pap smears reported as CIN 1. Acta Obstet. Gynecol. Scand. 2003, 82(8):756-761.
20. Jhala D., Eltoum I. Barriers to adoption of recent technology in cervical screening. CytoJournal 2007, 4:16.
21. Meissner H.I., Vernon S.W., Rimer B.K., et al. The future of research that promotes cancer screening. Cancer 2004, 101(5 Suppl.):1251-1259.
22. Meissner H.I., Klabunde C.N., Breen N., Zapka J.M. Breast and colorectal cancer screening: U.S. primary care physicians' reports of barriers. Am. J. Prev. Med. 2012, 43(6):584-589.
23. Monsonego J., Cortes J., da Silva D.P., Jorge A.F., Klein P. Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries. BMC Womens Health 2011, 11:1.
24. Munoz N., Bosch F.X., de Sanjose S., et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer 1992, 52(5):743-749.
25. Plescia M., Richardon L.C., Joseph D. New roles for public health in cancer screening. CA Cancer J. Clin. 2012, 62(4):217-219.
26. Roland K.B., Soman A., Benard V.B., Saraiya M. Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States. Am. J. Obstet. Gynecol. 2011, 205(5):447-448.
27. Roland K.B., Benard V.B., Soman A., Breen N., Kepka D., Saraiya M. Cervical cancer screening among young adult women in the United States. Cancer Epidemiol. Biomarker. Prev. 2013, 22(4):580-588. (Available from: http://cebp.aacrjournals.org/cgi/content/abstract/1055-9965.EPI-12-1266).
28. Saraiya M., Berkowitz Z., Yabroff K.R., Wideroff L., Kobrin S., Benard V. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?. Arch. Intern. Med. 2010, 170(11):977-985.
29. Saslow D., Runowicz C.D., Solomon D., et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J. Clin. 2002, 52(6):342-362.
30. Saslow D., Solomon D., Lawson H.W., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J. Low Genit. Tract Dis. 2012, 16(3):175-204.
31. Sheinfeld G.S., Gemson D., Ashford A., et al. Cancer education among primary care physicians in an underserved community. Am. J. Prev. Med. 2000, 19(1):53-58.
32. Sherman M.E., Lorincz A.T., Scott D.R., et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J. Natl. Cancer Inst. 2003, 95(1):46-52.
33. Sirovich B.E., Woloshin S., Schwartz L.M. Screening for cervical cancer: will women accept less?. Am. J. Med. 2005, 118(2):151-158.
34. Smith E.K., White M.C., Weir H.K., Peipins L.A., Thompson T.D. Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States. Cancer Causes Control 2012, 23(1):207-211.
35. Taplin S.H., Anhang P.R., Edwards H.M., et al. Introduction: understanding and influencing multilevel factors across the cancer care continuum. J. Natl. Cancer Inst. Monogr. 2012, 2012(44):2-10.
36. Tatsas A.D., Phelan D.F., Gravitt P.E., Boitnott J.K., Clark D.P. Practice patterns in cervical cancer screening and human papillomavirus testing. Am. J. Clin. Pathol. 2012, 138(2):223-229.
37. US Food and Drug Administration FDA approves expanded use of HPV test 2003, U.S. Food and Drug Administration, (http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm082556.htm. Accessed January 28, 2013).
38. US Preventive Services Task Force Recommendation Statement: Screening for Cervical Cancer 2012, Agency for Healthcare Research and Quality, (http://www.uspreventiveservicestaskforce.org/uspstf11/cervcancer/cervcancerrs.htm. Accessed January 28, 2013).
39. Walboomers J.M.M., Jacobs M.V., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12-19.
40. Wender R.C. Cancer screening and prevention in primary care. Obstacles for physicians. Cancer 1993, 72(3 Suppl.):1093-1099.
41. Yabroff K.R., Saraiya M., Meissner H.I., et al. Specialty differences in primary care physician reports of Papanicolaou test screening practices: a national survey, 2006 to 2007. Ann. Intern. Med. 2009, 151(9):602-611.
42. Yeager K.K., Donehoo R.S., Macera C.A., Croft J.B., Heath G.W., Lane M.J. Health promotion practices among physicians. Am. J. Prev. Med. 1996, 12(4):238-241.